ATTACKING HIV PROTEASE CLEAVAGE SITES WITH IMMUNIZATION - Explore the rapid mutation rate of HIV-1

通过免疫攻击 HIV 蛋白酶裂解位点 - 探索 HIV-1 的快速突变率

• 批准号: 183527
• 负责人: Luo Ma
• 金额: $ 7.29万
• 依托单位: University of Manitoba
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-03-01 至 2010-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=183527&lang=en
• 关键词: Hiv Protease Cleavage Sites; Hiv Vaccine Strategy; Mucosal Immunization; Nanodelivery; Vesicular Stomatitis Virus (Vsv) Vector

More than 25 years since HIV-1 was identified as the cause of AIDS, 60 million people have been infected and about half of them have died of HIV/AIDS. An effective vaccine is the only way to stop the epidemic, the failure of a series of vaccine trials bas

自艾滋病毒-1被确定为艾滋病的原因以来，已有6000万人受到感染，其中约一半人死于艾滋病毒/艾滋病。一种有效的疫苗是阻止疫情的唯一方法，一系列疫苗试验的失败